Fresenius SE Common Stock Net 2016-2024 | FSNUY
Fresenius SE common stock net from 2016 to 2024. Common stock net can be defined as the value of common equity ownership.
- Fresenius SE common stock net for the quarter ending June 30, 2024 was $0.606B, a 1.24% decline year-over-year.
- Fresenius SE common stock net for 2023 was $0.609B, a 2.72% increase from 2022.
- Fresenius SE common stock net for 2022 was $0.593B, a 10.15% decline from 2021.
- Fresenius SE common stock net for 2021 was $0.66B, a 3.76% increase from 2020.
Fresenius SE Annual Common Stock Net
(Millions of US $) |
| 2023 |
$609 |
| 2022 |
$593 |
| 2021 |
$660 |
| 2020 |
$636 |
| 2019 |
$624 |
| 2018 |
$657 |
| 2017 |
$627 |
| 2016 |
$605 |
| 2015 |
$606 |
Fresenius SE Quarterly Common Stock Net
(Millions of US $) |
| 2024-06-30 |
$606 |
| 2024-03-31 |
$611 |
| 2023-12-31 |
$609 |
| 2023-09-30 |
$613 |
| 2023-06-30 |
$614 |
| 2023-03-31 |
$604 |
| 2022-12-31 |
$593 |
| 2022-09-30 |
$567 |
| 2022-06-30 |
$599 |
| 2022-03-31 |
$626 |
| 2021-12-31 |
$660 |
| 2021-09-30 |
$658 |
| 2021-06-30 |
$672 |
| 2021-03-31 |
$672 |
| 2020-12-31 |
$636 |
| 2020-09-30 |
$651 |
| 2020-06-30 |
$613 |
| 2020-03-31 |
$614 |
| 2019-12-31 |
$624 |
| 2019-09-30 |
$619 |
| 2019-06-30 |
$626 |
| 2019-03-31 |
$632 |
| 2018-12-31 |
$657 |
| 2018-09-30 |
$646 |
| 2018-06-30 |
$663 |
| 2018-03-31 |
$682 |
| 2017-12-31 |
$627 |
| 2017-09-30 |
$652 |
| 2017-06-30 |
$609 |
| 2017-03-31 |
$589 |
| 2016-12-31 |
$605 |
| 2016-09-30 |
$605 |
| 2016-06-30 |
$617 |
| 2016-03-31 |
$602 |
| 2015-12-31 |
$606 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$20.039B |
$24.011B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
